Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The study is designed as a multicenter, double blind, parallel-group, placebo-controlled,
randomized, event driven Phase II study of DTIC with or without bosentan as first-line
treatment in patients with stage IV melanoma.